Cytotoxic effects of cantharidin on the growth of normal and carcinoma cells

被引:77
作者
Wang, CC
Wu, CH
Hsieh, KJ
Yen, KY
Yang, LL
机构
[1] Taipei Med Coll, Grad Inst Pharmacognosy Sci, Taipei, Taiwan
[2] Taipei Med Coll, Dept Anat, Taipei, Taiwan
关键词
cantharidin; hepatocellular carcinoma; cytotoxicity; nucleic acid biosynthesis; ultrastructure;
D O I
10.1016/S0300-483X(00)00185-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cantharidin is isolated from Mylabris phalerata Pallas and is a potent inhibitor of hepatocellular carcinoma cells (Hep 3B cells). In the present study, the IC50 values of cantharidin on Hep 3B cells and normal Chang liver cells were found to be 2.2 and 30.2 mu M for 36 h, respectively. Furthermore, cantharidin-treated Hep 3B cells induced cell death within 1 h (IC50 = 52.8 mu M): suggesting that cantharidin is an acute cytotoxic agent. We found that although cantharidin could induce cell death, it could not directly inhibit the activity of nucleic acid biosynthesis by the cellular incorporation of H-3-thymidine, H-3-uridine or H-3-leucine. Cantharidin-treated Hep 3B cells showed no evidence of major alterations in the cell cycle distribution within 1 h. However, examination of cells after treatment for 36 h showed that cantharidin regulated the cell cycle at the G(2)/M phase. Moreover, the treated Hep 3B cells had a rounded and shrunken appearance. The microvilli of treated Hep 3B cells were reduced in number and replaced by numerous blebs. Other ultrastructural changes following cantharidin treatment included the presence of lipid droplets, swelling of the mitochondria and accumulation of glycogen particles. The findings of damaged mitochondria in the cantharidin treated Hep 3B cells in this study suggest that cantharidin can induce acute and lethal toxic effects on Hep 3B cells by inhibiting the mitochondria energy system. In conclusion, this study had demonstrated that cantharidin could inhibit progression of all phases of the Hep 3B cell cycle. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:77 / 87
页数:11
相关论文
共 25 条
[1]  
Boobis A. R., 1992, OXFORD TXB PATHOLOGY, V1, P181
[2]  
Cheng AY, 1998, CANCER RES, V58, P3611
[3]   APPLICATION OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOR RECOGNITION OF COVALENT NUCLEIC-ACID MODIFICATION WITH ANTICANCER DRUGS [J].
CUMMINGS, J ;
FRENCH, RC ;
SMYTH, JF .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 618 (1-2) :251-276
[4]  
DARZYNKIEWICZ Z, 1984, CANCER RES, V44, P83
[5]   CANTHARIDIN EFFECTS ON PROTEIN PHOSPHATASES AND THE PHOSPHORYLATION STATE OF PHOSPHOPROTEINS IN MICE [J].
ELDRIDGE, R ;
CASIDA, JE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 130 (01) :95-100
[6]  
FRESHNEY RI, 1993, CULTURE ANIMAL CELLS, P276
[7]   CANTHARIDIN POISONING ASSOCIATED WITH SPECIFIC BINDING-SITE IN LIVER [J].
GRAZIANO, MJ ;
WATERHOUSE, AL ;
CASIDA, JE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 149 (01) :79-85
[8]  
GRAZIANO MJ, 1988, MOL PHARMACOL, V33, P706
[9]  
Huang Yao-Ge, 1997, Natural Medicines, V51, P471
[10]   POSTMORTEM SERUM CONCENTRATION OF CANTHARIDIN IN A FATAL CASE OF CANTHARIDES POISONING [J].
HUNDT, HKL ;
STEYN, JM ;
WAGNER, L .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1990, 9 (01) :35-40